Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 491

1.

Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.

Fiorenzato E, Biundo R, Cecchin D, Frigo AC, Kim J, Weis L, Strafella AP, Antonini A.

J Alzheimers Dis. 2018 Sep 26. doi: 10.3233/JAD-180390. [Epub ahead of print]

PMID:
30282359
2.

Apomorphine infusion in advanced Parkinson disease.

Antonini A, Jenner P.

Nat Rev Neurol. 2018 Oct 2. doi: 10.1038/s41582-018-0083-y. [Epub ahead of print] No abstract available.

PMID:
30279608
3.

USP14 inhibition corrects an in vivo model of impaired mitophagy.

Chakraborty J, von Stockum S, Marchesan E, Caicci F, Ferrari V, Rakovic A, Klein C, Antonini A, Bubacco L, Ziviani E.

EMBO Mol Med. 2018 Sep 24. pii: e9014. doi: 10.15252/emmm.201809014. [Epub ahead of print]

4.

Regulation of ER-mitochondria contacts by Parkin via Mfn2.

Basso V, Marchesan E, Peggion C, Chakraborty J, von Stockum S, Giacomello M, Ottolini D, Debattisti V, Caicci F, Tasca E, Pegoraro V, Angelini C, Antonini A, Bertoli A, Brini M, Ziviani E.

Pharmacol Res. 2018 Sep 13. pii: S1043-6618(18)30321-9. doi: 10.1016/j.phrs.2018.09.006. [Epub ahead of print]

5.

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.

Antonini A, Gentile G, Giglio M, Marcante A, Gage H, Touray MML, Fotiadis DI, Gatsios D, Konitsiotis S, Timotijevic L, Egan B, Hodgkins C, Biundo R, Pellicano C; PD_Manager consortium.

Trials. 2018 Sep 14;19(1):492. doi: 10.1186/s13063-018-2767-4.

6.

Disease progression in Parkinson subtypes: the PPMI dataset.

Aleksovski D, Miljkovic D, Bravi D, Antonini A.

Neurol Sci. 2018 Aug 14. doi: 10.1007/s10072-018-3522-z. [Epub ahead of print]

PMID:
30109466
7.

[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].

Antonini A, Jost WH.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S5-S9. doi: 10.1055/a-0646-4164. Epub 2018 Aug 14. German.

PMID:
30107620
8.

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.

Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA.

Curr Med Res Opin. 2018 Aug 20:1-11. doi: 10.1080/03007995.2018.1502165. [Epub ahead of print]

PMID:
30016901
9.

Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.

Antonini A, Nitu B.

J Neural Transm (Vienna). 2018 Jul 13. doi: 10.1007/s00702-018-1906-0. [Epub ahead of print] Review.

PMID:
30006821
10.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
11.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

12.

Interferon-beta injection site reactions in patients with multiple sclerosis.

Maurelli M, Bergamaschi R, Antonini A, Fargnoli MC, Puma E, Mallucci G, Totaro R, Girolomoni G.

J Dermatolog Treat. 2018 May 7:1-4. doi: 10.1080/09546634.2018.1467539. [Epub ahead of print]

PMID:
29671656
13.

Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.

Dafsari HS, Weiß L, Silverdale M, Rizos A, Reddy P, Ashkan K, Evans J, Reker P, Petry-Schmelzer JN, Samuel M, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):867-874. doi: 10.1016/j.brs.2018.02.015. Epub 2018 Feb 24.

PMID:
29655587
14.

Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.

Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L; EUROPAR; IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):904-912. doi: 10.1016/j.brs.2018.03.009. Epub 2018 Mar 16.

PMID:
29655586
15.

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.

Antonini A, Robieson WZ, Bergmann L, Yegin A, Poewe W.

Neurodegener Dis Manag. 2018 Jun;8(3):161-170. doi: 10.2217/nmt-2017-0046. Epub 2018 Apr 10.

16.

Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.

Chondrogiorgi M, Astrakas LG, Zikou AK, Weis L, Xydis VG, Antonini A, Argyropoulou MI, Konitsiotis S.

Brain Imaging Behav. 2018 Apr 9. doi: 10.1007/s11682-018-9863-7. [Epub ahead of print]

PMID:
29629498
17.

A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis.

Micantonio T, Neri L, Longo C, Grassi S, Di Stefani A, Antonini A, Coco V, Fargnoli MC, Argenziano G, Peris K.

Eur J Dermatol. 2018 Apr 1;28(2):162-168. doi: 10.1684/ejd.2018.3246.

PMID:
29620004
18.

Medical and surgical management of advanced Parkinson's disease.

Antonini A, Moro E, Godeiro C, Reichmann H.

Mov Disord. 2018 Jul;33(6):900-908. doi: 10.1002/mds.27340. Epub 2018 Mar 23. Review.

PMID:
29570862
19.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
20.

Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study.

Tessitore A, Marano P, Modugno N, Pontieri FE, Tambasco N, Canesi M, Latorre A, Lopiano L, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Costanzo AM, Gualberti G, di Luzio Paparatti U, Antonini A.

J Neurol. 2018 May;265(5):1124-1137. doi: 10.1007/s00415-018-8816-9. Epub 2018 Mar 7.

21.

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.

Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2018 Mar;33(3):421-430. doi: 10.1002/mds.27283. Epub 2018 Feb 21.

PMID:
29465787
22.

DBS for Parkinson's disease with behavioural disturbances.

Antonini A, Obeso JA.

Lancet Neurol. 2018 Mar;17(3):195-197. doi: 10.1016/S1474-4422(18)30044-9. No abstract available.

PMID:
29452675
23.

Relevance of sleep quality on caregiver burden in Parkinson's disease.

Bartolomei L, Pastore A, Meligrana L, Sanson E, Bonetto N, Minicuci GM, Marsala SZ, Mesiano T, Bragagnolo L, Antonini A.

Neurol Sci. 2018 May;39(5):835-839. doi: 10.1007/s10072-018-3252-2. Epub 2018 Feb 14.

PMID:
29445989
24.

Workers' Exposure to Nano-Objects with Different Dimensionalities in R&D Laboratories: Measurement Strategy and Field Studies.

Boccuni F, Ferrante R, Tombolini F, Lega D, Antonini A, Alvino A, Pingue P, Beltram F, Sorba L, Piazza V, Gemmi M, Porcari A, Iavicoli S.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E349. doi: 10.3390/ijms19020349.

25.

Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.

Dafsari HS, Reker P, Silverdale M, Reddy P, Pilleri M, Martinez-Martin P, Rizos A, Perrier E, Weiß L, Ashkan K, Samuel M, Evans J, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non-Motor PD Study Group.

Neuromodulation. 2018 Aug;21(6):532-540. doi: 10.1111/ner.12740. Epub 2017 Dec 20.

PMID:
29266613
26.

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Catalán MJ, Antonini A, Calopa M, Băjenaru O, de Fábregues O, Mínguez-Castellanos A, Odin P, García-Moreno JM, Pedersen SW, Pirtošek Z, Kulisevsky J.

eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep. Review.

27.

Peri-electrode edema after bilateral subthalamic deep brain stimulation for Parkinson's disease.

Trezza A, Landi A, Pilleri M, Antonini A, Giussani C, Sganzerla EP.

J Neurosurg Sci. 2018 Feb;62(1):103-105. doi: 10.23736/S0390-5616.16.03421-4. No abstract available.

PMID:
29239165
28.

Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis.

Antonini A, Caioli S, Saba L, Vindigni G, Biocca S, Canu N, Zona C.

Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):509-519. doi: 10.1016/j.bbadis.2017.11.008. Epub 2017 Nov 24.

PMID:
29154925
29.

Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.

Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, Timmermann L; EUROPAR and the IPMDS (International Parkinson's and Movement Disorders Society) Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2018 Jan;33(1):99-107. doi: 10.1002/mds.27222. Epub 2017 Nov 18.

PMID:
29150860
30.

The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.

Bellucci A, Antonini A, Pizzi M, Spano P.

Front Aging Neurosci. 2017 Oct 10;9:330. doi: 10.3389/fnagi.2017.00330. eCollection 2017.

31.

Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis.

Pellegrini C, Di Nardo L, Cipolloni G, Martorelli C, De Padova M, Antonini A, Maturo MG, Del Regno L, Strafella S, Micantonio T, Leocata P, Peris K, Fargnoli MC.

J Mol Diagn. 2018 Jan;20(1):110-122. doi: 10.1016/j.jmoldx.2017.10.002. Epub 2017 Oct 20.

PMID:
29061376
32.

Predicting rapid progression of Parkinson's Disease at baseline patients evaluation.

Tsiouris KM, Rigas G, Gatsios D, Antonini A, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3898-3901. doi: 10.1109/EMBC.2017.8037708.

PMID:
29060749
33.

Testing feasibility of an accurate microscopic assessment of macrovesicular steatosis in liver allograft biopsies by smartphone add-on lenses.

Cesaretti M, Poté N, Dondero F, Cauchy F, Schneck AS, Soubrane O, Paradis V, Diaspro A, Antonini A.

Microsc Res Tech. 2018 Jan;81(1):58-63. doi: 10.1002/jemt.22956. Epub 2017 Oct 17.

PMID:
29044859
34.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

35.

The peroneus brevis flap in the treatment of bone infections of the lower limb.

Antonini A, Rossello C, Salomone C, Riccio G, Felli L, Burastero G.

Injury. 2017 Oct;48 Suppl 3:S76-S79. doi: 10.1016/S0020-1383(17)30663-0.

PMID:
29025616
36.

Nutritional habits, risk, and progression of Parkinson disease.

Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M.

J Neurol. 2018 Jan;265(1):12-23. doi: 10.1007/s00415-017-8639-0. Epub 2017 Oct 10. Review.

PMID:
29018983
37.

Below Knee Stump Reconstruction with a Foot Fillet Flap.

Tos P, Antonini A, Pugliese P, Panero B, Ciclamini D, Battiston B.

J Reconstr Microsurg. 2017 Oct;33(S 01):S20-S26. doi: 10.1055/s-0037-1606538. Epub 2017 Oct 6. No abstract available.

PMID:
28985635
38.

Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?

Biundo R, Weis L, Fiorenzato E, Antonini A.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):840-860. doi: 10.1093/arclin/acx092. Review.

PMID:
28961738
39.

Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.

Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC, Lopiano L, Marconi R, Matinella A, Morgante F, Nicoletti A, Tamburini T, Tinazzi M, Zappia M, Vorovenci RJ, Antonini A.

Mov Disord. 2017 Nov;32(11):1557-1565. doi: 10.1002/mds.27181. Epub 2017 Sep 27.

PMID:
28960475
40.

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.

Fabbri M, Guimarães I, Cardoso R, Coelho M, Guedes LC, Rosa MM, Godinho C, Abreu D, Gonçalves N, Antonini A, Ferreira JJ.

Front Neurol. 2017 Aug 22;8:432. doi: 10.3389/fneur.2017.00432. eCollection 2017.

41.

The Propeller Concept Applied to Free Flaps and the Proposal of a "Clock Flap" Nomenclature.

Antonini A, Rossello C, Salomone C, Carrega G, Felli L, Burastero G.

J Reconstr Microsurg. 2017 Oct;33(S 01):S48-S52. doi: 10.1055/s-0037-1606269. Epub 2017 Aug 25. No abstract available.

PMID:
28841734
42.

Real-Time Rain Rate Evaluation via Satellite Downlink Signal Attenuation Measurement.

Giannetti F, Reggiannini R, Moretti M, Adirosi E, Baldini L, Facheris L, Antonini A, Melani S, Bacci G, Petrolino A, Vaccaro A.

Sensors (Basel). 2017 Aug 12;17(8). pii: E1864. doi: 10.3390/s17081864.

43.

Understanding and Treating Pain Syndromes in Parkinson's Disease.

Gandolfi M, Geroin C, Antonini A, Smania N, Tinazzi M.

Int Rev Neurobiol. 2017;134:827-858. doi: 10.1016/bs.irn.2017.05.013. Epub 2017 Jul 3. Review.

PMID:
28805585
44.

Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.

Biundo R, Fiorenzato E, Antonini A.

Int Rev Neurobiol. 2017;133:389-415. doi: 10.1016/bs.irn.2017.05.031. Epub 2017 Jul 13. Review.

PMID:
28802926
45.

Cognitive decline in Parkinson's disease: the complex picture.

Biundo R, Weis L, Antonini A.

NPJ Parkinsons Dis. 2016 Sep 1;2:16018. doi: 10.1038/npjparkd.2016.18. eCollection 2016. Review.

46.

PD_Manager: an mHealth platform for Parkinson's disease patient management.

Tsiouris KM, Gatsios D, Rigas G, Miljkovic D, Koroušić Seljak B, Bohanec M, Arredondo MT, Antonini A, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Healthc Technol Lett. 2017 May 23;4(3):102-108. doi: 10.1049/htl.2017.0007. eCollection 2017 Jun.

47.

Cognitive impairment in multiple system atrophy.

Fiorenzato E, Antonini A, Wenning G, Biundo R.

Mov Disord. 2017 Sep;32(9):1338-1339. doi: 10.1002/mds.27085. Epub 2017 Jul 3. Review. No abstract available.

PMID:
28671311
48.

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.

Fabbri M, Reimão S, Carvalho M, Nunes RG, Abreu D, Guedes LC, Bouça R, Lobo PP, Godinho C, Coelho M, Gonçalves NC, Rosa MM, Antonini A, Ferreira JJ.

J Parkinsons Dis. 2017;7(3):491-501. doi: 10.3233/JPD-171135.

PMID:
28671143
49.

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.

de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ.

J Parkinsons Dis. 2017;7(3):533-543. doi: 10.3233/JPD-161055.

50.

Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale.

Martinez-Martin P, Manuel Rojo-Abuin J, Rizos A, Rodriguez-Blazquez C, Trenkwalder C, Perkins L, Sauerbier A, Odin P, Antonini A, Chaudhuri KR; KPPS, EUROPAR and the IPMDS Non Motor PD Study Group.

NPJ Parkinsons Dis. 2017 Mar 15;3:8. doi: 10.1038/s41531-017-0009-1. eCollection 2017.

Supplemental Content

Loading ...
Support Center